119 related articles for article (PubMed ID: 18630510)
1. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
Bäckman U; Svensson A; Christofferson RH; Azarbayjani F
Anticancer Res; 2008; 28(3A):1551-7. PubMed ID: 18630510
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis can be reduced without significant reduction of tumor growth.
Svensson A; Bäckman U; Fuchs D; Christofferson R; Azarbayjani F
Anticancer Res; 2007; 27(6B):3883-9. PubMed ID: 18225546
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
5. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
[TBL] [Abstract][Full Text] [Related]
7. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma.
Wassberg E; Hedborg F; Sköldenberg E; Stridsberg M; Christofferson R
Am J Pathol; 1999 Feb; 154(2):395-403. PubMed ID: 10027398
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of TNP-470 on hepatic metastasis of mouse neuroblastoma.
Yoshizawa J; Mizuno R; Yoshida T; Hara A; Ashizuka S; Kanai M; Kuwashima N; Kurobe M; Yamazaki Y
J Surg Res; 2000 Sep; 93(1):82-7. PubMed ID: 10945947
[TBL] [Abstract][Full Text] [Related]
10. A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.
Kosharskyy B; Solban N; Chang SK; Rizvi I; Chang Y; Hasan T
Cancer Res; 2006 Nov; 66(22):10953-8. PubMed ID: 17108133
[TBL] [Abstract][Full Text] [Related]
11. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood J; Bonjean K; Ruetz S; Bellahcène A; Devy L; Foidart JM; Castronovo V; Green JR
J Pharmacol Exp Ther; 2002 Sep; 302(3):1055-61. PubMed ID: 12183663
[TBL] [Abstract][Full Text] [Related]
12. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats.
Wassberg E; Påhlman S; Westlin JE; Christofferson R
Pediatr Res; 1997 Mar; 41(3):327-33. PubMed ID: 9078530
[TBL] [Abstract][Full Text] [Related]
13. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA
Cancer Res; 2007 Oct; 67(19):9435-42. PubMed ID: 17909053
[TBL] [Abstract][Full Text] [Related]
14. CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs.
Svensson A; Bäckman U; Jonsson E; Larsson R; Christofferson R
Pediatr Res; 2002 May; 51(5):607-11. PubMed ID: 11978885
[TBL] [Abstract][Full Text] [Related]
15. The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.
Rössler J; Monnet Y; Farace F; Opolon P; Daudigeos-Dubus E; Bourredjem A; Vassal G; Geoerger B
Int J Cancer; 2011 Jun; 128(11):2748-58. PubMed ID: 20715103
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
Ma J; Pulfer S; Li S; Chu J; Reed K; Gallo JM
Cancer Res; 2001 Jul; 61(14):5491-8. PubMed ID: 11454697
[TBL] [Abstract][Full Text] [Related]
17. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
[TBL] [Abstract][Full Text] [Related]
18. Angiostatic treatment of neuroblastoma.
Wassberg E
Ups J Med Sci; 1999; 104(1):1-24. PubMed ID: 10374667
[TBL] [Abstract][Full Text] [Related]
19. Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis.
Hou L; Mori D; Takase Y; Meihua P; Kai K; Tokunaga O
Pathol Int; 2009 Jul; 59(7):448-61. PubMed ID: 19563408
[TBL] [Abstract][Full Text] [Related]
20. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
